NY0123 is a potent and selective EPAC antagonist exhibiting inhibitory activity in the low micromolar range. This small molecule is a valuable research tool for investigating cAMP/EPAC signaling pathways in both cellular and animal models of cancer and cardiovascular disease.
Molekulargewicht:
399.66
CAS Nummer:
[1801911-70-5]
Formel:
C16H13Cl3N4O2
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten